title: Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment.
authors.forename: Thomas
authors.initials: T
authors.lastname: Daikeler
authors.forename: Gideon
authors.initials: G
authors.lastname: Hoenger
authors.forename: Ineke
authors.initials: I
authors.lastname: Oehri
authors.forename: Alan
authors.initials: A
authors.lastname: Tyndall
authors.forename: Alois
authors.initials: A
authors.lastname: Gratwohl
authors.forename: Christian
authors.initials: C
authors.lastname: Brander
authors.forename: Thomas
authors.initials: T
authors.lastname: Klimkait
authors.forename: Olivier
authors.initials: O
authors.lastname: Gasser
authors.forename: Christoph
authors.initials: C
authors.lastname: Hess
mesh_terms: D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
chemical_list: D000956:Antigens, Viral; D007166:Immunosuppressive Agents